8.2.1 Antiproliferative immunosuppressants
Azathioprine
Azathioprine 25mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Malignant disease and immunosuppression | Solid organ transplantation |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Azathioprine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Malignant disease and immunosuppression | Solid organ transplantation |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Methotrexate
Methotrexate 2.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 10mg/0.2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 12.5mg/0.25ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 17.5mg/0.35ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 20mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 25mg/0.5ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 7.5mg/0.15ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Methotrexate
Methotrexate 2.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 10mg/0.2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 12.5mg/0.25ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 17.5mg/0.35ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 20mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 25mg/0.5ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 7.5mg/0.15ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Methotrexate
Methotrexate 2.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 10mg/0.2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 12.5mg/0.25ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 17.5mg/0.35ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 20mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 25mg/0.5ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 7.5mg/0.15ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Mycophenolate mofetil
Mycophenolate mofetil 250mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Malignant disease and immunosuppression | Solid organ transplantation |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Mycophenolate mofetil 500mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Malignant disease and immunosuppression | Solid organ transplantation |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Interstitial Lung Disease |
Mycophenolic acid
Mycophenolic acid 360mg gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |